Genetics & Genomics

Co-principal investigators of the genomic-enabled learning health system coordinating center and clinical site are, front row from left, Carolyn Audet, PhD, Alexander Bick, MD, PhD, and Sunil Kripalani, MD, MSc, and, back row from left, Wesley Self, MD, MPH, Josh Peterson, MD, MPH, and Dan Roden, MD. (photo by Susan Urmy)
September 24, 2024

‘Learning’ network will help move genomics into the clinic

A real-world learning health system was established at VUMC a decade ago. Now, the National Human Genome Research Institute is awarding two five-year grants totaling $12 million to support VUMC’s participation in, and coordination of, a genomic-enabled learning health system (gLHS) network.

Melinda Aldrich, PhD, MPH
September 20, 2024

Melinda Aldrich elected to genetics society board of directors

Aldrich uses population-based cohorts and biobanks to investigate lung cancer; her research informed guidelines for lung cancer screening.

Venki Ramakrishnan, PhD
September 12, 2024

Nobel laureate to speak at VUMC on the ribosome and ‘why we die’

The subject of his Discovery Lecture, which will begin at 4 p.m. Sept. 26 in 208 Light Hall, is the role of ribosomes in initiating the translation of DNA into RNA, a precursor step to transcribing the genetic code into proteins that do the work of the cell.

August 13, 2024

$3.4 million research grant targets risk of heart attack, stroke

Making innovative use of observational data, researchers hope to gain new understanding of patient risk and identify existing drugs to lower risk.

August 7, 2024

Epigenetic change to DNA associated with cancer risk in ‘multiomics’ study

The new study identifies 4,248 CpG sites associated with the risk of seven different types of cancer: breast, colorectal, renal cell, lung, ovarian, prostate and testicular germ cell cancers.

Atrial Fibrillation Precision Research Program clinic team members arrange genetic testing for patients with AFib. (photo by Erin O. Smith)
August 7, 2024

Program arranges genetic testing for AFib patients who may be at risk for inherited cardiomyopathy or arrhythmia syndromes

Without treatment, younger patients may develop other serious cardiac disorders such as heart failure or life-threatening ventricular arrhythmias.